{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-23T12:27:59.983534+00:00",
  "news": [
    {
      "title": "Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOUDdVRGpzZWhQMjNDRWs5Szdob0pIMDdveUNiNTg5RlFnQ0ZJNGJmRUJUUkVsUGlIanhSNF9GcmdfNXhEOEJWN0hxa3RfQkRkVVAyS3p4b1poS0s1NjZQSmJQNVhlbGc4aHYtWFA3a3A0aXZFb29BWEtOb0V5dHVYYQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxOUDdVRGpzZWhQMjNDRWs5Szdob0pIMDdveUNiNTg5RlFnQ0ZJNGJmRUJUUkVsUGlIanhSNF9GcmdfNXhEOEJWN0hxa3RfQkRkVVAyS3p4b1poS0s1NjZQSmJQNVhlbGc4aHYtWFA3a3A0aXZFb29BWEtOb0V5dHVYYQ?oc=5\" target=\"_blank\">Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-22T23:11:30+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen Faces 340B Lawsuit Spotlighting Drug Pricing And Investor Risks - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Amgen Faces 340B Lawsuit Spotlighting Drug Pricing And Investor Risks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-22T22:53:29+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcjU3YXZwYlBDc1k5dHdCcnJnMlhoeC16WlZyTWQzdWpfS1JiMWlsU3kwTjVGVDgyTXlma1l1d0ZrdUF0dnVYcFBpMjhoUUlLVjRDZjZIMFV6SFN4MEgzSVJVUlZFQjRPUENkcnB3cWlfeEEwWUtFSk5hVWU5bUFLZlVmamVLYmRNWUJOV2xZYTZFOV9FVGU0NHJRTVB4VjYxWktSZXhJSDRjZjM1MEpHekxqbXpPU1FpS0p3dXItZm4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPcjU3YXZwYlBDc1k5dHdCcnJnMlhoeC16WlZyTWQzdWpfS1JiMWlsU3kwTjVGVDgyTXlma1l1d0ZrdUF0dnVYcFBpMjhoUUlLVjRDZjZIMFV6SFN4MEgzSVJVUlZFQjRPUENkcnB3cWlfeEEwWUtFSk5hVWU5bUFLZlVmamVLYmRNWUJOV2xZYTZFOV9FVGU0NHJRTVB4VjYxWktSZXhJSDRjZjM1MEpHekxqbXpPU1FpS0p3dXItZm4?oc=5\" target=\"_blank\">AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2026-01-12T23:45:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPVGljZl9CV1hyalRuVmx4eHlUeWpLQWg1WEV4VjAzNFpYdVpBclBJYW1oSk1VMXp2MXpYcUZQNURXU25CYVF2TnRlY0pZRHdTcDY2ck1aYWo5bHhkZDVMa1RVWEF5cU1hN2xmb0pibExiOFZtdnFxdkNhNGJoSmVOZUdndmdGTXBFWFNKVXZFeUtQVHFMcGgzWQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPVGljZl9CV1hyalRuVmx4eHlUeWpLQWg1WEV4VjAzNFpYdVpBclBJYW1oSk1VMXp2MXpYcUZQNURXU25CYVF2TnRlY0pZRHdTcDY2ck1aYWo5bHhkZDVMa1RVWEF5cU1hN2xmb0pibExiOFZtdnFxdkNhNGJoSmVOZUdndmdGTXBFWFNKVXZFeUtQVHFMcGgzWQ?oc=5\" target=\"_blank\">Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2026-01-22T23:00:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Sagebrush sues Amgen over 340B program row - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxOV3FNclBBVmlyd3pVVnM4UkYxT3pSNDJnT012RDBBRnczQ2hrR0YwalZRa1FpUlBSUF91NmVEQWthd3NURi1CM0VubHFiLTNyRzhSdjhpaktoNnZrY0xFazBhSDRBV3BnVTU5RUpudW9BbENCeTc5Zkt1Y1U5aWVLRHhxMjVuSVE5MEtFZ3k3REg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxOV3FNclBBVmlyd3pVVnM4UkYxT3pSNDJnT012RDBBRnczQ2hrR0YwalZRa1FpUlBSUF91NmVEQWthd3NURi1CM0VubHFiLTNyRzhSdjhpaktoNnZrY0xFazBhSDRBV3BnVTU5RUpudW9BbENCeTc5Zkt1Y1U5aWVLRHhxMjVuSVE5MEtFZ3k3REg?oc=5\" target=\"_blank\">Sagebrush sues Amgen over 340B program row</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2026-01-22T13:25:23+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Women’s Economic Ventures names Amgen’s DeAnna Steiger, Ph.D. as Board Chair Inbox Business News - edhat.com",
      "link": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQdzdlUHFKYk9uS0JuaGVFbVo5YjdhV3h0N3VOTTlUU0JGbms2V3M0dDN1UGp1ZFhDRjltYmJNSnpvRzZNdFNsNTJtbzlZQk1Ea0VkU3VWalU3YVpfSmxSMkUyMHZjS2syal9RVHZFZ3hEVHRVcGR0ZGh0aWIwd3h0ZmFtOUU3XzRpcjdBQTFRU0NkMk0yRVJPVXFaM2l4d1l6ZWZSM0VVTy0wMC1lUlNSOXY1eUpqMVNxSTBFLWFvWTQ2czl1d2lLMw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQdzdlUHFKYk9uS0JuaGVFbVo5YjdhV3h0N3VOTTlUU0JGbms2V3M0dDN1UGp1ZFhDRjltYmJNSnpvRzZNdFNsNTJtbzlZQk1Ea0VkU3VWalU3YVpfSmxSMkUyMHZjS2syal9RVHZFZ3hEVHRVcGR0ZGh0aWIwd3h0ZmFtOUU3XzRpcjdBQTFRU0NkMk0yRVJPVXFaM2l4d1l6ZWZSM0VVTy0wMC1lUlNSOXY1eUpqMVNxSTBFLWFvWTQ2czl1d2lLMw?oc=5\" target=\"_blank\">Women’s Economic Ventures names Amgen’s DeAnna Steiger, Ph.D. as Board Chair Inbox Business News</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">edhat.com</font>",
      "published": "2026-01-23T05:19:58+00:00",
      "source": "edhat.com"
    },
    {
      "title": "Amgen: A Buy In 2026 On Exciting MariTide Obesity - T2D Potential (NASDAQ:AMGN) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNWWZsQl9zZUpYdnpvZC0wd1BJSUt2X0xHcThRWjRkVXFLcjl6YVFxaWxWTWdibm41QkVRcjc2T1FKNlZ5aFVKZUZxWGVnOTFBNGpyckY2MW9MQkRpeHVEWTlZUXYyUDdiMTdpQ2RoeFlWY1drSlpDX1ZEd1dUckluWnJXcTVtTjdPdGhnUUxVcmh0UjJ0a19MWEhBVkZpekgxSTZfWEl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxNWWZsQl9zZUpYdnpvZC0wd1BJSUt2X0xHcThRWjRkVXFLcjl6YVFxaWxWTWdibm41QkVRcjc2T1FKNlZ5aFVKZUZxWGVnOTFBNGpyckY2MW9MQkRpeHVEWTlZUXYyUDdiMTdpQ2RoeFlWY1drSlpDX1ZEd1dUckluWnJXcTVtTjdPdGhnUUxVcmh0UjJ0a19MWEhBVkZpekgxSTZfWEl3?oc=5\" target=\"_blank\">Amgen: A Buy In 2026 On Exciting MariTide Obesity - T2D Potential (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2026-01-22T16:15:34+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Ro partners with Amgen to study barriers to obesity care, GLP-1 access - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQUEpDQ2FuOHRlZDhZZ3ZoRUM0ejJlTktVSm1QN3J3RE02N0s2ZUZyeFBmekNyalJ2OUhhOW53MFNqWkJCLTBvTllSR0N0WTBadlNLUTNyenAya29nR0dVVE5kU3VRcWpoRktaNFJuWjh2Tm5TWTJVSXpVTTZ2NDZwQWFfZF9iUVFRNm9zSC1LSDdySEtiZzR6bUF5ZlYtSEloYTVjUzZ4V3U0TTU2TmEtX0YxR3MyS0hfT2FCaERSUlk0M1JjQW0xd0I1OTBqcWFENXhKM0hn?oc=5\" target=\"_blank\">Ro partners with Amgen to study barriers to obesity care, GLP-1 access</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2026-01-13T08:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - Amgen",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaE9rZlFxUjZZSGd5Yk85X1ZoVGtfQ0NTYW9jV1pQLVNfbU5tUmV2NGRFdnZpaUNoLTFCV2RxNEgzTmUxdS11OHpWczc2ZDFhblp3WjB2dzZ0el9JQjgwMWFDc3dpTU5LTk5yeHZEaExDVVUwb2JBR1RDZHNTTUpaWXhFWnR6M3V5VlVhb3dENHh4LVpRMDlrNFZrWkdnOWlXTGt6cEozc1JKeEg1OW5WOWZBMjB6SFd6eFRmSTBSMl8xbmJXX0pyWk1GMllyeUZiX1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPaE9rZlFxUjZZSGd5Yk85X1ZoVGtfQ0NTYW9jV1pQLVNfbU5tUmV2NGRFdnZpaUNoLTFCV2RxNEgzTmUxdS11OHpWczc2ZDFhblp3WjB2dzZ0el9JQjgwMWFDc3dpTU5LTk5yeHZEaExDVVUwb2JBR1RDZHNTTUpaWXhFWnR6M3V5VlVhb3dENHh4LVpRMDlrNFZrWkdnOWlXTGt6cEozc1JKeEg1OW5WOWZBMjB6SFd6eFRmSTBSMl8xbmJXX0pyWk1GMllyeUZiX1E?oc=5\" target=\"_blank\">AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5\" target=\"_blank\">A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-02T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    },
    {
      "title": "AMGEN INC SEC 10-Q Report - TradingView — Track All Markets",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxPLWF3RE1KR2s2WllnYnFjZUNKQlJTWFBhRDFTQ3N6TVN1QjR4ME9KOUltb0NpTFI2Ylh3THNsbVR6UV96OVpvZDFNZ2dEQTFzOW5RT0ItWXVmanQ0dGQ3LXlqeThNdHVzeU90VXJzcHZKZHJBeVpZNko2QUo2aTh0U3hseVpmbEFVODVvdUxjM1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxPLWF3RE1KR2s2WllnYnFjZUNKQlJTWFBhRDFTQ3N6TVN1QjR4ME9KOUltb0NpTFI2Ylh3THNsbVR6UV96OVpvZDFNZ2dEQTFzOW5RT0ItWXVmanQ0dGQ3LXlqeThNdHVzeU90VXJzcHZKZHJBeVpZNko2QUo2aTh0U3hseVpmbEFVODVvdUxjM1E?oc=5\" target=\"_blank\">AMGEN INC SEC 10-Q Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView — Track All Markets</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "TradingView — Track All Markets"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-22",
      "close": 347.07000732421875
    },
    "history": [
      {
        "date": "2026-01-13",
        "close": 324.29998779296875
      },
      {
        "date": "2026-01-14",
        "close": 328.9700012207031
      },
      {
        "date": "2026-01-15",
        "close": 330.0299987792969
      },
      {
        "date": "2026-01-16",
        "close": 330.4100036621094
      },
      {
        "date": "2026-01-20",
        "close": 331.0
      },
      {
        "date": "2026-01-21",
        "close": 343.6000061035156
      },
      {
        "date": "2026-01-22",
        "close": 347.07000732421875
      }
    ],
    "name": "Amgen Inc."
  }
}